Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Korro Bio (KRRO) Other Operating Expenses (2019 - 2025)

Korro Bio (KRRO) has disclosed Other Operating Expenses for 2 consecutive years, with $67.4 million as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Other Operating Expenses changed N/A year-over-year to $67.4 million, compared with a TTM value of $67.4 million through Sep 2024, changed N/A, and an annual FY2023 reading of $54.8 million, changed N/A over the prior year.
  • Other Operating Expenses was $67.4 million for Q4 2023 at Korro Bio, up from -$10.1 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $67.4 million in Q4 2023 and bottomed at -$10.1 million in Q3 2020.